Antibacterial Activity of Rationally Designed Antimicrobial Peptides
Many infectious diseases are still prevalent in the world’s populations since no effective treatments are available to eradicate them. The reasons may either be the antibiotic resistance towards the available therapeutic molecules or the slow rate of producing adequate therapeutic regimens to tackle...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | International Journal of Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2020/2131535 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832553947332608000 |
|---|---|
| author | Marius B. Tincho Thureyah Morris Mervin Meyer Ashley Pretorius |
| author_facet | Marius B. Tincho Thureyah Morris Mervin Meyer Ashley Pretorius |
| author_sort | Marius B. Tincho |
| collection | DOAJ |
| description | Many infectious diseases are still prevalent in the world’s populations since no effective treatments are available to eradicate them. The reasons may either be the antibiotic resistance towards the available therapeutic molecules or the slow rate of producing adequate therapeutic regimens to tackle the rapid growth of new infectious diseases, as well as the toxicity of current treatment regimens. Due to these reasons, there is a need to seek and develop novel therapeutic regimens to reduce the rapid scale of bacterial infections. Antimicrobial Peptides (AMPs) are components of the first line of defense for prokaryotes and eukaryotes and have a wide range of activities against Gram-negative and Gram-positive bacteria, fungi, cancer cells, and protozoa, as well as viruses. In this study, peptides which were initially identified for their HIV inhibitory activity were further screened for antibacterial activity through determination of their kinetics as well as their cytotoxicity. From the results obtained, the MICs of two AMPs (Molecule 3 and Molecule 7) were 12.5 μg/ml for K. pneumoniae (ATCC 700603) and 6.25 μg/ml for P. aeruginosa (ATCC 22108). The two AMPs killed these bacteria rapidly in vitro, preventing bacterial growth within few hours of treatment. Furthermore, the cytotoxic activity of these two peptides was significantly low, even at an AMP concentration of 100 μg/ml. These results revealed that Molecule 3 and 7 have great potential as antibacterial drugs or could serve as lead compounds in the design of therapeutic regimens for the treatment of antibiotic-resistant bacteria. |
| format | Article |
| id | doaj-art-6bd4ea24292f4a7e875199befb96af72 |
| institution | Kabale University |
| issn | 1687-918X 1687-9198 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Microbiology |
| spelling | doaj-art-6bd4ea24292f4a7e875199befb96af722025-02-03T05:52:43ZengWileyInternational Journal of Microbiology1687-918X1687-91982020-01-01202010.1155/2020/21315352131535Antibacterial Activity of Rationally Designed Antimicrobial PeptidesMarius B. Tincho0Thureyah Morris1Mervin Meyer2Ashley Pretorius3Bioinformatics Research Group (BRG), DST/Mintek Nanotechnology Innovation Centre–Biolabels Node, Department of Biotechnology, Faculty of Natural Sciences, University of the Western Cape, Bellville 7535, South AfricaFood Toxicology Laboratory, Department of Medical Bioscience, Faculty of Natural Sciences, University of the Western Cape, Bellville 7535, South AfricaDST/Mintek Nanotechnology Innovation Centre–Biolabels Node, Department of Biotechnology, Faculty of Natural Sciences, University of the Western Cape, Bellville 7535, South AfricaBioinformatics Research Group (BRG), DST/Mintek Nanotechnology Innovation Centre–Biolabels Node, Department of Biotechnology, Faculty of Natural Sciences, University of the Western Cape, Bellville 7535, South AfricaMany infectious diseases are still prevalent in the world’s populations since no effective treatments are available to eradicate them. The reasons may either be the antibiotic resistance towards the available therapeutic molecules or the slow rate of producing adequate therapeutic regimens to tackle the rapid growth of new infectious diseases, as well as the toxicity of current treatment regimens. Due to these reasons, there is a need to seek and develop novel therapeutic regimens to reduce the rapid scale of bacterial infections. Antimicrobial Peptides (AMPs) are components of the first line of defense for prokaryotes and eukaryotes and have a wide range of activities against Gram-negative and Gram-positive bacteria, fungi, cancer cells, and protozoa, as well as viruses. In this study, peptides which were initially identified for their HIV inhibitory activity were further screened for antibacterial activity through determination of their kinetics as well as their cytotoxicity. From the results obtained, the MICs of two AMPs (Molecule 3 and Molecule 7) were 12.5 μg/ml for K. pneumoniae (ATCC 700603) and 6.25 μg/ml for P. aeruginosa (ATCC 22108). The two AMPs killed these bacteria rapidly in vitro, preventing bacterial growth within few hours of treatment. Furthermore, the cytotoxic activity of these two peptides was significantly low, even at an AMP concentration of 100 μg/ml. These results revealed that Molecule 3 and 7 have great potential as antibacterial drugs or could serve as lead compounds in the design of therapeutic regimens for the treatment of antibiotic-resistant bacteria.http://dx.doi.org/10.1155/2020/2131535 |
| spellingShingle | Marius B. Tincho Thureyah Morris Mervin Meyer Ashley Pretorius Antibacterial Activity of Rationally Designed Antimicrobial Peptides International Journal of Microbiology |
| title | Antibacterial Activity of Rationally Designed Antimicrobial Peptides |
| title_full | Antibacterial Activity of Rationally Designed Antimicrobial Peptides |
| title_fullStr | Antibacterial Activity of Rationally Designed Antimicrobial Peptides |
| title_full_unstemmed | Antibacterial Activity of Rationally Designed Antimicrobial Peptides |
| title_short | Antibacterial Activity of Rationally Designed Antimicrobial Peptides |
| title_sort | antibacterial activity of rationally designed antimicrobial peptides |
| url | http://dx.doi.org/10.1155/2020/2131535 |
| work_keys_str_mv | AT mariusbtincho antibacterialactivityofrationallydesignedantimicrobialpeptides AT thureyahmorris antibacterialactivityofrationallydesignedantimicrobialpeptides AT mervinmeyer antibacterialactivityofrationallydesignedantimicrobialpeptides AT ashleypretorius antibacterialactivityofrationallydesignedantimicrobialpeptides |